Research and Markets: Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process
Press Release: Research and Markets – 4 hours
agoResearch and Markets (http://www.researchandmarkets.com/research/4tnkzb/emerging_pharmaceu) has announced the addition of the "Emerging Pharmaceutical Market in South Africa to 2017 - Proposed Introduction of New Drug Regulatory Agency (SAHPRA) to Accelerate Drug Registration Process" report to their offering.
South African Bid to Tackle AIDS Epidemic to Create National Pharmaceutical Market Boom
The South African pharmaceutical market is expected to almost double in the next six years due to profitable government contracts for HIV/AIDS and tuberculosis medications, according to the latest report from market analysts GBI Research.
The new report predicts that the South African pharmaceutical industry will grow from a value of $3.8 billion in 2011 to $7 billion in 2018, climbing at a Compound Annual Growth Rate (CAGR) of 9.2%.
Though it was once dismissed as low-profit, the country's pharmaceutical industry is now regarded as having great potential and is attracting the attention of some of the sector's big players.
To tackle South Africa's crippling problem with HIV/AIDS and TB, the government is awarding tenders that promise steady returns for two to three years to companies offering appropriate treatments.